CardioNet (BioTelemetry)

Founded in 2000, CardioNet was the first company to provide heartbeat-by-heartbeat monitoring, physician reporting and urgent response for patients as they went about their normal daily activities.

CardioNet technology and service center support allowed quick diagnosis and treatment for patients with episodic, potentially life-threatening heart problems that are difficult to detect. CardioNet ultimately sold to Philips in 2021 for $2.8 billion.

CAPS

A “just in time” IV medications preparation service for hospital pharmacies and clinical trials, allowing a high-technology, state-of-the-art level of quality control nationwide in preparing complex, high-risk intravenous medications and nutritional formulations.